Shareholder Communications

Notice of rights of members in connection with certain documents

Emyria Limited (ACN 625 085 734) (Company) gives notice pursuant to section 110K of the Corporations Act 2001 (Cth) (Corporations Act) of the rights of members (Shareholder) to:

  • elect to receive or not receive certain documents; and
  • make requests to be sent certain documents in physical or electronic form

The Company is required to send the following documents to Shareholders, and Shareholders are entitled to receive:

  • documents that relate to a meeting of Shareholders, such as a notice of meeting or proxy or voting forms;
  • the Annual Report (comprising the financial report, directors’ report and auditor’s report for the relevant financial year); and
  • a notice of members’ rights under section 110K of the Corporations Act (such as this notice), unless the notice is readily available on a website, together with any other documents prescribed by relevant regulations, (collectively, “the Documents”).

Your right to make an election

Each Shareholder is entitled to:

(a) elect to be sent Documents in either physical form or electronic form; and

(b) elect not to be sent the Annual Report (and any other documents prescribed by the relevant regulations),
by notifying the Company of the election.

A Shareholder may make an election in relation to all Documents or a specified class(es) of Documents.

The Company encourages all Shareholders to receive communications electronically both to ensure that you stay informed and reflecting our commitment to minimising paper usage.

In addition to any election, a Shareholder is also entitled to request the Company to send a particular Document to the Shareholder in physical form or in electronic form.

Notifying the Company of your election Or Request

You can make your election and/or request by contacting our share registry directly: 

1300 288 664 (within Australia)
+61 (0)2 9698 5414 (Overseas)

Emyria Limited Rights Issue

Emyria is launching a Rights Issue that will allow eligible shareholders to increase their shareholding in Emyria.
This Capital Raising effort, targeting up to $3.1 million, will  help fast-track Emyria’s mental healthcare programs, including MDMA-assisted therapy for PTSD, novel drug development, and payer engagement, while also supporting potential revenue growth and data collection.

Every Eligible Shareholder holding Emyria shares by the Record Date (Wednesday, 13th September, 2023) can contribute to Emyria’s growth and is welcome to apply for shares priced at $0.075 per new fully paid ordinary share. This presents an opportunity for shareholders to be an integral part of Emyria’s development journey.

The Entitlement Offer opens, 18 September 2023, and is expected to close at 5.00pm (AWST) on 28 September 2023 (unless extended). Application monies must be received as cleared funds prior to this time, in accordance with the terms of the Prospectus and Application Form. 


You are encouraged to carefully read the terms and conditions of the Offer set out in this document, because if you apply for Shares under the Rights Issue you will be agreeing to be bound by the Terms and Conditions.

By applying for Shares under the Rights Issue you will confirm that you have read, understood and agreed to the Terms and Conditions


For all enquiries concerning the Entitlement Offer
please contact the Company by telephone on +61 (08) 6559 2800 or email on

For all general shareholder enquiries, please contact the Company’s Share Registry, 
Automic Pty Ltd, on +1300 288 664.

Target Market Determination

Emyria has prepared this target market determination (TMD) in relation to the offer of approximately 20,556,621 free attaching options to be issued to Eligible Shareholders (and other investors invited by the Directors) (Options) with an exercise price of $0.12 each and expiring 3 years from the date of issue (Offer).

Call 08 6559 2800Contact